 Thyroid Neoplasms
"Thyroid Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the THYROID GLAND.
| Descriptor ID |
D013964
|
| MeSH Number(s) |
C04.588.322.894 C04.588.443.915 C19.344.894 C19.874.788
|
| Concept/Terms |
Thyroid Neoplasms- Thyroid Neoplasms
- Neoplasm, Thyroid
- Thyroid Neoplasm
- Neoplasms, Thyroid
Thyroid Carcinoma- Thyroid Carcinoma
- Carcinoma, Thyroid
- Carcinomas, Thyroid
- Thyroid Carcinomas
- Cancer of Thyroid
- Thyroid Cancers
- Thyroid Cancer
- Cancer, Thyroid
- Cancers, Thyroid
- Cancer of the Thyroid
Thyroid Adenoma- Thyroid Adenoma
- Adenoma, Thyroid
- Adenomas, Thyroid
- Thyroid Adenomas
|
Below are MeSH descriptors whose meaning is more general than "Thyroid Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Thyroid Neoplasms".
This graph shows the total number of publications written about "Thyroid Neoplasms" by people in this website by year, and whether "Thyroid Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 | | 1996 | 2 | 0 | 2 | | 1997 | 2 | 2 | 4 | | 1998 | 4 | 1 | 5 | | 1999 | 2 | 0 | 2 | | 2000 | 3 | 1 | 4 | | 2001 | 2 | 0 | 2 | | 2002 | 5 | 0 | 5 | | 2003 | 2 | 0 | 2 | | 2004 | 8 | 0 | 8 | | 2005 | 1 | 1 | 2 | | 2006 | 8 | 1 | 9 | | 2007 | 1 | 1 | 2 | | 2008 | 4 | 0 | 4 | | 2009 | 7 | 0 | 7 | | 2010 | 10 | 2 | 12 | | 2011 | 1 | 1 | 2 | | 2012 | 8 | 0 | 8 | | 2013 | 10 | 2 | 12 | | 2014 | 9 | 0 | 9 | | 2015 | 15 | 1 | 16 | | 2016 | 7 | 3 | 10 | | 2017 | 11 | 0 | 11 | | 2018 | 14 | 0 | 14 | | 2019 | 7 | 0 | 7 | | 2020 | 8 | 0 | 8 | | 2021 | 9 | 1 | 10 | | 2022 | 12 | 0 | 12 | | 2023 | 9 | 0 | 9 | | 2024 | 13 | 1 | 14 | | 2025 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Thyroid Neoplasms" by people in Profiles.
-
Leboulleux S, Boucai L, Busaidy N, Durante C, Fagin JA, Fazeli S, Gianoukakis AG, Haugen BR, Kang H, Konda B, Laetsch TW, Locati L, Ryder M, Spitzweg C, Worden FP, Wirth L, Ho A. Redifferentiation therapy in unresectable or metastatic radioactive iodine refractory thyroid cancer: an International Thyroid Oncology Group statement. Lancet Diabetes Endocrinol. 2025 06; 13(6):516-527.
-
Ahmadi S, Kotwal A, Bikas A, Xiang P, Goldner W, Patel A, Hughes EG, Longstaff X, Yeh MW, Livhits MJ. Outcomes of Cytologically Indeterminate Thyroid Nodules Managed With Genomic Sequencing Classifier. J Clin Endocrinol Metab. 2024 Nov 18; 109(12):e2231-e2239.
-
Barrio MJ, Pozdeyev N, McIntyre RC, Albuja-Cruz MB, Haugen BR, Raeburn CD. Long term outcomes after repeat lymph node dissections for persistent or recurrent differentiated thyroid cancer. Am J Surg. 2025 Jan; 239:116045.
-
French JD, Haugen BR, Worden FP, Bowles DW, Gianoukakis AG, Konda B, Dadu R, Sherman EJ, McCue S, Foster NR, Nikiforov YE, Farias TDJ, Norman PJ, Wirth LJ. Combination Targeted Therapy with Pembrolizumab and Lenvatinib in Progressive, Radioiodine-Refractory Differentiated Thyroid Cancers. Clin Cancer Res. 2024 Sep 03; 30(17):3757-3767.
-
Kotwal A, Fingeret A, Knape A, Patel A, Bradford Bell E, Goldner W. Thyroid Cancer Survivorship: Challenges and Opportunities. Endocr Pract. 2024 Nov; 30(11):1097-1102.
-
Goldner W. The Role of Age in the Risk Assessment of Differentiated Thyroid Cancers. J Clin Endocrinol Metab. 2024 Jul 12; 109(8):e1673-e1674.
-
Kotwal A, Vance K, Hajric K, Yuil-Valdes A, Swanson B, Martinez Duarte E, Shats O, Hollingsworth M, Band H, Goldner W. Characterization of Immune Infiltrate Along the Leading Edge of Differentiated Thyroid Cancer. Thyroid. 2024 Aug; 34(8):999-1006.
-
Barrio MJ, Pozdeyev N, Raeburn CD, McIntyre RC, Marshall CB, Haugen B, La Greca A. Pre-operative thyroglobulin measurement for thyroid cancer risk of recurrence and response to therapy. Am J Surg. 2024 Dec; 238:115818.
-
Kotwal A, Simpson R, Whiteman N, Swanson B, Yuil-Valdes A, Fitch M, Nguyen J, Elhag S, Shats O, Goldner W, Bennett R. Relaxin-2 is a novel biomarker for differentiated thyroid carcinoma in humans. Biochem Pharmacol. 2024 07; 225:116323.
-
Hicks HM, Nassar VL, Lund J, Rose MM, Schweppe RE. The effects of Aurora Kinase inhibition on thyroid cancer growth and sensitivity to MAPK-directed therapies. Cancer Biol Ther. 2024 Dec 31; 25(1):2332000.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|